Purchase our oncology module on a standalone basis or together with other modules and solutions across our full portfolio to create an integrated, tailor-made research platform.
With increasing drug development cost, growing pressure on healthcare expenditures and requirement for more efficacious treatment, the oncology market faces tremendous challenges. The revolution is yet to come with the development of better, yet cheaper, targeted therapies and broader use of genetic screening and biomarkers.
GlobalData has developed a team of analysts with the expertise to know what makes the oncology market so different. Our union of diagnostics, patient segmentations, treatment algorithms and forecasting methodologies, makes us well-placed to deliver powerful insights that allow you to make informed strategic decisions and keep abreast of the more recent developments in the field.
GlobalData's therapy module includes coverage from cancers across the therapy area, including lymphomas, leukemia and sarcomas.